FDA debates trial-data secrecy

Heidi Ledford

Nature, 2014, vol. 511, issue 7511, 519-519

Abstract: US drug regulator weighs up merits of disclosing preliminary results.

Date: 2014
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/511519a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:511:y:2014:i:7511:d:10.1038_511519a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/511519a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().